This company has been marked as potentially delisted and may not be actively trading. NASDAQ:APHA Aphria (APHA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Aphria Stock (NASDAQ:APHA) 30 days 90 days 365 days Advanced Chart Get Aphria alerts:Sign Up Key Stats Today's Range$15.38▼$15.3850-Day Range$13.14▼$18.3752-Week Range$2.78▼$32.29VolumeN/AAverage Volume21.83 million shsMarket Capitalization$4.87 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada. Read More Receive APHA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aphria and its competitors with MarketBeat's FREE daily newsletter. Email Address APHA Stock News HeadlinesRochon Genova: Did You Purchase Shares of Aphria Inc. (“Aphria”) After January 29, 2018 and Hold Them Until March 23, 2018 and/or December 3, 2018?May 12, 2025 | businesswire.comTilray stock touches 52-week low at $0.94 amid market challengesFebruary 11, 2025 | msn.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.August 24 at 2:00 AM | Brownstone Research (Ad)Tilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth OpportunitiesJuly 29, 2024 | markets.businessinsider.comTilray's Aphria RX awarded German cannabis trading licenseJuly 29, 2024 | msn.comHorse Racing UK & Ireland ResultsMay 21, 2024 | bbc.comBSheep Ate 600lbs Of Cannabis While Sheltering From A Storm: Here's What They Did NextSeptember 27, 2023 | benzinga.comEwe Won't Believe It: Greek Sheep's 'Highly' Unconventional Cannabis Greenhouse AdventureSeptember 25, 2023 | markets.businessinsider.comSee More Headlines APHA Stock Analysis - Frequently Asked Questions How were Aphria's earnings last quarter? Aphria Inc. (NASDAQ:APHA) posted its quarterly earnings data on Sunday, April, 11th. The company reported ($1.14) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $1.10. The firm's quarterly revenue was up 6.4% on a year-over-year basis. What other stocks do shareholders of Aphria own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Tilray Brands (TLRY), Cronos Group (CRON), NVIDIA (NVDA), Tesla (TSLA) and NIO (NIO). Company Calendar Last Earnings4/11/2021Today8/24/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & Botanicals Sub-IndustryN/A Current SymbolNASDAQ:APHA CIKN/A Webaphriainc.com Phone(844) 427-4742FaxN/AEmployees1,200Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$63.21 million Net Margins-36.10% Pretax MarginN/A Return on Equity-2.30% Return on Assets-1.66% Debt Debt-to-Equity Ratio0.25 Current Ratio2.36 Quick Ratio1.17 Sales & Book Value Annual Sales$405.96 million Price / Sales12.00 Cash Flow$0.09 per share Price / Cash Flow166.43 Book Value$4.80 per share Price / Book3.20Miscellaneous Outstanding Shares316,795,000Free FloatN/AMarket Cap$4.87 billion OptionableOptionable Beta2.67 Social Links The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:APHA) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aphria Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aphria With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access